Public Pitch
Welcome to the Nucleate Germany Activator Finalist Public Pitch!
Join us for an exciting virtual evening of ideas, insights, inspiration, and aspiration as our nine finalist teams pitch their visionary life science ventures. Whether you're a student, researcher, investor, or simply curious, this event is open to all who want to witness and support the next wave of biotech innovation.
Agenda:
Introduction to Nucleate and the Activator program
Judges Introduction
Meet the expert panel evaluating the pitches: Stephen Grant (Senior Biotech Executive, Boston), Anela Vukoja (Principal, Apollo Health Ventures), Natalya Baltrukovich (Investment Manager, HTGF)
Finalist Team Pitches
Each team will give a 5-minute pitch followed by a 5-minute live Q&A
Closing Remarks
Meet the Finalist Teams
EpiCure is advancing the development of Carbacitabin (CAB), a novel epigenetic compound showing promising activity against blood cancers.
circular grain (ehem. tremi) is revolutionizing the milk alternative sector with Tremi, the most sustainable plant-based dairy.
Oncera is dedicated to transforming scientific insights into practical biotech solutions, aiming to turn cancer into a manageable disease.
Aulixir Therapeutics addresses the challenges of severe side effects and poor solubility in life-saving drugs using a proprietary drug delivery platform of sugar-stabilized gold nanoparticles
NovInCell Therapeutics is developing a first-in-class therapy to protect the brain during acute ischemic stroke (AIS) by enhancing vascular integrity through selective inhibition of PI3KC2β.
Keynostic is developing a rapid, at-home test that provides semi-quantitative results for multiple vitamins simultaneously.
ROXimmune is developing a first-in-class prodrug platform to treat inflammatory diseases at their root.
ExoSphere is developing a highly sensitive and affordable diagnostic platform based on magnetic flow cytometry to detect cancer biomarkers at extremely low concentrations, enabling earlier and more accurate cancer diagnostics.
Aster Bioelectronics is building intracellular bio-nano transceivers, with the ambitious goal of turning cells into smart sensors for real-time monitoring and control.
Come with questions—or just curiosity—and leave inspired by the future of science-driven entrepreneurship.
Registrations are open and accepted on a rolling basis—don’t miss your chance to be part of the journey!
We can’t wait to see you there!
About the Event Host
Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.xyz for more information, and visit https://nucleate.xyz/privacy-policy/ to read our privacy policy.